Benitec Biopharma
BNTC
BNTC
14 hedge funds and large institutions have $1.84M invested in Benitec Biopharma in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 0.45% → 0.47% (+0.01%)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$462K | |
| 2 | +$371K | |
| 3 | +$270K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$147K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$120K |
Top Sellers
| 1 | -$324K | |
| 2 | -$282K | |
| 3 | -$171K | |
| 4 |
Renaissance Technologies
New York
|
-$152K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$47K |